Identity and synonyms
Identity follows the supplied name and synonyms; no additional identity description is supplied.
Protein or biologic · Protein or protein analogue
Detailed molecular class: Glycoprotein hormone
Supplied sequence or chemical reference
See identity note; no supplier sequence accepted as verification.
Mechanism
LH receptor activity.
Evidence and critical reading
Reported scientific and empirical uses
Fertility and reproduction
Chorionic gonadotropin with endocrine/reproductive indications; distinguish origin, potency and formulation.
Human evidence
Pregnyl has defined reproductive/endocrine indications.
Preclinical evidence
Not evidence for weight loss.
Critical reading and limitations
Fertility/hypogonadism use does not validate hCG diets or fat loss on its own.
Evidence applies to the exact molecule, formulation, route, population and endpoint studied. Supplier identity, purity and clinical equivalence are unverified.
Source-specific regimens
Descriptive source observations, not individual recommendations.
Regulatory product labeling
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Human-study exposure
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Empirical handbook
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Regulation and safety
Jurisdiction-specific regulatory context
US: Pregnyl labeling verified; source-vial equivalence not established.
Adverse effects and unknowns
Hypersensitivity and ovarian hyperstimulation risks require exact-label assessment. Interaction with other fertility treatment is a clinical combination context, not a wellness-stack validation.
Label/population determine contraindications; do not calculate dosing from total vial potency.
Contraindications
See supported safety statements and exact product label; a complete contraindication set has not been established for this catalog material.
A complete list must match the exact authorized product. For experimental materials without verified human labeling, a complete contraindication set is not established here. No list does not mean safety.
Interactions
Only explicitly cited interactions may be asserted; unstudied combinations remain unknown, not interaction-free.
Separate documented interaction, pharmacologic plausibility and unknown interaction. Absence of a blend trial does not establish compatibility.
Studies and trials
Selected studies
No selected studies are attributed in this record.
Trials attributed in the package
No trials are attributed in this record.
Trial registration does not establish efficacy or validate commercial material.
Query candidates; attribution pending
chorionic gonadotropin · 407 unfiltered query results, not authenticated trials
Query verification: October 16, 2026
Exact phrase intervention query; first three most recently updated records, not exhaustive. Aliases may be missed and heterogeneous products may appear. The total is the unfiltered registry query count, not authenticated trials. Source-integrity holds are excluded from ordinary listings.
View trial registry queryNCT07557615 · hCG Treatment for Rehabilitation From a TBIRegistry status: Not yet recruitingLast update posted: October 13, 2026Query verification: October 16, 2026
NCT07861399 · Dual Trigger VS HCG Trigger for Final Oocyte Maturation in Normal RespondersRegistry status: RecruitingLast update posted: October 6, 2026Query verification: October 16, 2026
NCT07425990 · FET-LET-2x2: Clinical Pregnancy Rates After Frozen Embryo Transfer in Natural and Modified Natural CyclesRegistry status: RecruitingLast update posted: September 29, 2026Query verification: October 16, 2026
Source issues and references
References include queries and bibliographic handbook attributions; not all are clinical studies. Human review remains pending.
- REG-HCG
October 16, 2026
- pdf01
PEPNEXA 2.pdf
October 16, 2026
- pdf02
ELLA PEPTIDES.pdf
October 16, 2026
- pdf03
zlz list 26.8.5.pdf
October 16, 2026
- pdf05
PEPNEXA.pdf
October 16, 2026
- pdf09
PeptideFactory.pdf
October 16, 2026